Effects of bromocriptine on dopamine turnover with or without levodopa

N. Ogawa, Masato Asanuma, K. Tanaka, K. Matsuura, K. Iida, M. Yamamoto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bromocriptine, a dopamine agonist, alleviates symptoms of Parkinson's disease, even when administered alone, and is used for its treatment. Better therapeutic effects are, however, achieved when bromocriptine is used in combination with levodopa. In this study, we examined the biochemical changes caused by bromocriptine administration with and without levodopa, and evaluated the effects of the treatments on dopamine turnover in the mouse striatum. Results show that dopamine turnover is suppressed by the administration of bromocriptine alone with a slight decrease in the amount of dopamine, and dopamine turnover is very strongly promoted by the administration of levodopa. When the two drugs are administered together, bromocriptine enhances the levodopa-induced increase in dopamine turnover in the striatum. These findings indicate that bromocriptine therapy in combination with levodopa enhances the dopaminergic function and suggest that the combination therapy of bromocriptine and levodopa shows good efficacy. The results of this study may, thus, provide a theoretical basis for the combination therapy of bromocriptine and levodopa.

Original languageEnglish
Pages (from-to)271-277
Number of pages7
JournalJournal of International Medical Research
Volume24
Issue number3
Publication statusPublished - May 1996

Fingerprint

Bromocriptine
Levodopa
Dopamine
Dopamine Agonists
Therapeutic Uses
Parkinson Disease
Therapeutics
Pharmaceutical Preparations

Keywords

  • Bromocriptine
  • Combination therapy
  • Dopamine
  • Dopamine turnover
  • Levodopa
  • Metabolite

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ogawa, N., Asanuma, M., Tanaka, K., Matsuura, K., Iida, K., & Yamamoto, M. (1996). Effects of bromocriptine on dopamine turnover with or without levodopa. Journal of International Medical Research, 24(3), 271-277.

Effects of bromocriptine on dopamine turnover with or without levodopa. / Ogawa, N.; Asanuma, Masato; Tanaka, K.; Matsuura, K.; Iida, K.; Yamamoto, M.

In: Journal of International Medical Research, Vol. 24, No. 3, 05.1996, p. 271-277.

Research output: Contribution to journalArticle

Ogawa, N, Asanuma, M, Tanaka, K, Matsuura, K, Iida, K & Yamamoto, M 1996, 'Effects of bromocriptine on dopamine turnover with or without levodopa', Journal of International Medical Research, vol. 24, no. 3, pp. 271-277.
Ogawa, N. ; Asanuma, Masato ; Tanaka, K. ; Matsuura, K. ; Iida, K. ; Yamamoto, M. / Effects of bromocriptine on dopamine turnover with or without levodopa. In: Journal of International Medical Research. 1996 ; Vol. 24, No. 3. pp. 271-277.
@article{c4f689e51f804c06a0ef122837899c3b,
title = "Effects of bromocriptine on dopamine turnover with or without levodopa",
abstract = "Bromocriptine, a dopamine agonist, alleviates symptoms of Parkinson's disease, even when administered alone, and is used for its treatment. Better therapeutic effects are, however, achieved when bromocriptine is used in combination with levodopa. In this study, we examined the biochemical changes caused by bromocriptine administration with and without levodopa, and evaluated the effects of the treatments on dopamine turnover in the mouse striatum. Results show that dopamine turnover is suppressed by the administration of bromocriptine alone with a slight decrease in the amount of dopamine, and dopamine turnover is very strongly promoted by the administration of levodopa. When the two drugs are administered together, bromocriptine enhances the levodopa-induced increase in dopamine turnover in the striatum. These findings indicate that bromocriptine therapy in combination with levodopa enhances the dopaminergic function and suggest that the combination therapy of bromocriptine and levodopa shows good efficacy. The results of this study may, thus, provide a theoretical basis for the combination therapy of bromocriptine and levodopa.",
keywords = "Bromocriptine, Combination therapy, Dopamine, Dopamine turnover, Levodopa, Metabolite",
author = "N. Ogawa and Masato Asanuma and K. Tanaka and K. Matsuura and K. Iida and M. Yamamoto",
year = "1996",
month = "5",
language = "English",
volume = "24",
pages = "271--277",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "3",

}

TY - JOUR

T1 - Effects of bromocriptine on dopamine turnover with or without levodopa

AU - Ogawa, N.

AU - Asanuma, Masato

AU - Tanaka, K.

AU - Matsuura, K.

AU - Iida, K.

AU - Yamamoto, M.

PY - 1996/5

Y1 - 1996/5

N2 - Bromocriptine, a dopamine agonist, alleviates symptoms of Parkinson's disease, even when administered alone, and is used for its treatment. Better therapeutic effects are, however, achieved when bromocriptine is used in combination with levodopa. In this study, we examined the biochemical changes caused by bromocriptine administration with and without levodopa, and evaluated the effects of the treatments on dopamine turnover in the mouse striatum. Results show that dopamine turnover is suppressed by the administration of bromocriptine alone with a slight decrease in the amount of dopamine, and dopamine turnover is very strongly promoted by the administration of levodopa. When the two drugs are administered together, bromocriptine enhances the levodopa-induced increase in dopamine turnover in the striatum. These findings indicate that bromocriptine therapy in combination with levodopa enhances the dopaminergic function and suggest that the combination therapy of bromocriptine and levodopa shows good efficacy. The results of this study may, thus, provide a theoretical basis for the combination therapy of bromocriptine and levodopa.

AB - Bromocriptine, a dopamine agonist, alleviates symptoms of Parkinson's disease, even when administered alone, and is used for its treatment. Better therapeutic effects are, however, achieved when bromocriptine is used in combination with levodopa. In this study, we examined the biochemical changes caused by bromocriptine administration with and without levodopa, and evaluated the effects of the treatments on dopamine turnover in the mouse striatum. Results show that dopamine turnover is suppressed by the administration of bromocriptine alone with a slight decrease in the amount of dopamine, and dopamine turnover is very strongly promoted by the administration of levodopa. When the two drugs are administered together, bromocriptine enhances the levodopa-induced increase in dopamine turnover in the striatum. These findings indicate that bromocriptine therapy in combination with levodopa enhances the dopaminergic function and suggest that the combination therapy of bromocriptine and levodopa shows good efficacy. The results of this study may, thus, provide a theoretical basis for the combination therapy of bromocriptine and levodopa.

KW - Bromocriptine

KW - Combination therapy

KW - Dopamine

KW - Dopamine turnover

KW - Levodopa

KW - Metabolite

UR - http://www.scopus.com/inward/record.url?scp=0029903056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029903056&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 271

EP - 277

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 3

ER -